2-(2-methoxy-4-(4-methylpiperazin-1-yl)phenylamino)-5H-benzo[d]pyrimido[4,5-f][1,3]diazepin-6(7H)-one

ID: ALA4793238

PubChem CID: 162670350

Max Phase: Preclinical

Molecular Formula: C23H25N7O2

Molecular Weight: 431.50

Molecule Type: Unknown

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  COc1cc(N2CCN(C)CC2)ccc1Nc1ncc2c(n1)-c1ccccc1NC(=O)N2

Standard InChI:  InChI=1S/C23H25N7O2/c1-29-9-11-30(12-10-29)15-7-8-18(20(13-15)32-2)25-22-24-14-19-21(28-22)16-5-3-4-6-17(16)26-23(31)27-19/h3-8,13-14H,9-12H2,1-2H3,(H,24,25,28)(H2,26,27,31)

Standard InChI Key:  JOBYLQCEIUUKAR-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 32 36  0  0  0  0  0  0  0  0999 V2000
    5.0421   -3.4132    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.0409   -4.2327    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.7490   -4.6417    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.7472   -3.0043    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.4588   -4.2336    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.4558   -3.4096    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.1008   -2.8876    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    7.9086   -3.0628    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.2701   -3.8063    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    7.9179   -4.5566    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.1127   -4.7444    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.8742   -5.5340    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.4399   -6.1366    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.2472   -5.9442    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.4819   -5.1549    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.4135   -2.4202    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.3329   -4.6408    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.3322   -5.4579    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6241   -5.8644    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6231   -6.6809    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.3310   -7.0908    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.0414   -6.6784    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.0389   -5.8633    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9171   -5.4545    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.2087   -5.8618    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.3315   -7.9080    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.6213   -8.3137    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6198   -9.1274    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.3259   -9.5394    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.0352   -9.1317    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.0384   -8.3119    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.3233  -10.3566    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  5  2  0
  6  4  2  0
  4  1  1  0
  5  6  1  0
  6  7  1  0
  5 11  1  0
  7  8  1  0
  8  9  1  0
 10  9  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 10  1  0
  8 16  2  0
  2 17  1  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  2  0
 21 22  1  0
 22 23  2  0
 23 18  1  0
 19 24  1  0
 24 25  1  0
 21 26  1  0
 26 27  1  0
 26 31  1  0
 27 28  1  0
 28 29  1  0
 29 30  1  0
 30 31  1  0
 29 32  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4793238

    ---

Associated Targets(Human)

TNK2 Tclin Tyrosine kinase non-receptor protein 2 (2836 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

BaF3 (4657 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 431.50Molecular Weight (Monoisotopic): 431.2070AlogP: 3.61#Rotatable Bonds: 4
Polar Surface Area: 94.65Molecular Species: NEUTRALHBA: 7HBD: 3
#RO5 Violations: HBA (Lipinski): 9HBD (Lipinski): 3#RO5 Violations (Lipinski):
CX Acidic pKa: 12.72CX Basic pKa: 7.84CX LogP: 3.17CX LogD: 2.59
Aromatic Rings: 3Heavy Atoms: 32QED Weighted: 0.58Np Likeness Score: -1.19

References

1. Li Z,Powell CE,Groendyke BJ,Gero TW,Feru F,Feutrill J,Chen B,Li B,Szabo H,Gray NS,Scott DA.  (2020)  Discovery of a series of benzopyrimidodiazepinone TNK2 inhibitors via scaffold morphing.,  30  (19): [PMID:32739400] [10.1016/j.bmcl.2020.127456]

Source